Medtronic Launches the MiniMed(TM) 670G System Performance Guarantee for Payers and Employers

Author's Avatar
Jun 28, 2018
Article's Main Image

DUBLIN- June 28, 2018 - Medtronic plc (NYSE:MDT, Financial), the global leader in medical technology, today announced the launch of the MiniMed(TM) 670G Performance Guarantee Program - an outcomes-based offering for payers and employers designed to mitigate costs for diabetes-related complications. With this Guarantee, Medtronic will provide flat-fee reimbursements up to $25,000 per pump over 4 years for qualifying diabetes-related inpatient hospitalization and emergency room admissions for eligible in-network patients in the United States.